Changes in antipsychotics and other psychotropic drugs during a 30-month lifestyle intervention among outpatients with schizophrenia.

Mikkel HojlundAnja Friis ElliottNikolaj Juul MadsenAnne Grethe ViuffPovl Munk-JørgensenPeter Hjorth

Published in: Nordic journal of psychiatry (2017)

Most patients decreased or stabilized their total dose of antipsychotic medication during the study period. Many patients were subject to antipsychotic polypharmacy. The extent of participation in the lifestyle intervention program did not correlate with the changes in dosing of antipsychotic medication.

Keyphrases

end stage renal disease
newly diagnosed
randomized controlled trial
ejection fraction
chronic kidney disease
physical activity
metabolic syndrome
prognostic factors
peritoneal dialysis
bipolar disorder
emergency department
type diabetes
patient reported outcomes
drug induced